Comparison of Efficacy of Allogenic Bone Marrow Transplantation With Cytoreduction and Chemotherapy in ALL Patients
Phase 2/Phase 3
16 Years
50 Years
16 Years
50 Years
Not Enrolling
Both
Acute Lymphoblastic Leukemia
Both
Acute Lymphoblastic Leukemia
Trial Information
Comparison of Efficacy of Allogenic Bone Marrow Transplantation With Cytoreduction and Chemotherapy in ALL Patients
Inclusion Criteria:
- Diagnose of Acute lymphoblastic leukemia
- Age between 16 to 50 year
- New case of ALL
Exclusion Criteria:
- Primary CNS involvement
- Primary Testis involvement
- Previously treated
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Efficacy of allogenic BMT compare with cytoreduction and chemotherapy in ALL patient
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Ardeshir Ghavamzadeh, MD
Investigator Role:
Study Chair
Investigator Affiliation:
Hematology-Oncology and SCT Research Center
Authority:
Iran: Ministry of Health
Study ID:
HORCSCT-0903
NCT ID:
NCT01015261
Start Date:
October 2008
Completion Date:
September 2010
Related Keywords:
- Acute Lymphoblastic Leukemia
- ALL
- BMT
- Chemotherapy
- Allogenic
- Leukemia
- Leukemia, Lymphoid
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
Name | Location |
|---|
